Anna Flamigni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anna Flamigni has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Gilda Paternuosto
Institute for Maternal and Child Health, IRCCS Burlo Garofolo, 34137 Trieste, Italy
3 shared publications - Giulia Schillani
Institute for Maternal and Child Health, IRCCS Burlo Garofolo, 34137 Trieste, Italy
2 shared publications - Alessandra Gianoncelli
Elettra Sincrotrone Trieste, Basovizza, Trieste, Italy
1 shared publication - Alessandra Maestro
Institute for Maternal and Child Health-IRCCS Burlo Garofolo, via dell’Istria 65/1, 34137 Trieste, Italy
1 shared publication Anna Arbo
Institute for Maternal and Child Health, IRCCS Burlo Garofolo Trieste Italy
1 shared publication- Anna Arbo
Institute for Maternal and Child Health (IRCCS Burlo Garofolo) Trieste Italy
1 shared publication
Latest Publications
- Open Access
- 29 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (19) , 6906
Decentralized Clinical Trials in Pediatrics: Is Italy Ready?
Driven by technological advances and regulatory developments, the clinical trials industry is undergoing a period of transformation. Decentralized clinical trials (DCTs) promise to streamline processes, increase participant engagement and improve data quality. The pediatric clinical trial landscape is challenging, as participation in a clinical trial affects the whole family. DCTs allow for increased patient engagement, thereby improving trial quality and consequently drug safety. The Italian Medicines Agency (AIFA), in its quest for regulatory simplification and alignment with the European framework, has established comprehensive guidelines to facilitate these decentralized trials. The present work aims to delve into the regulations to understand the feasibility of conducting decentralized pediatric trials in Italy.
- 29 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (19) , 6906
Open AccessDecentralized Clinical Trials in Pediatrics: Is Italy Ready?
Driven by technological advances and regulatory developments, the clinical trials industry is undergoing a period of transformation. Decentralized clinical trials (DCTs) promise to streamline processes, increase participant engagement and improve data quality. The pediatric clinical trial landscape is challenging, as participation in a clinical trial affects the whole family. DCTs allow for increased patient engagement, thereby improving trial quality and consequently drug safety. The Italian Medicines Agency (AIFA), in its quest for regulatory simplification and alignment with the European framework, has established comprehensive guidelines to facilitate these decentralized trials. The present work aims to delve into the regulations to understand the feasibility of conducting decentralized pediatric trials in Italy.
- Open Access
Impact of Iron Overload and Hypomagnesemia Combination on Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Outcomes
Background/Objectives: Pediatric allogeneic hematopoietic stem cell transplantation (allo-HSCT) is complicated by iron overload and hypomagnesemia, both contributing to immune dysfunction and post-transplant morbidity. The combined impact of these metabolic disturbances on pediatric allo-HSCT outcomes remains unexplored. This study aims to determine whether hypomagnesemia can serve as a prognostic biomarker for delayed immune reconstitution and explores its interplay with iron overload in predicting post-transplant complications and survival outcomes. Methods: A retrospective analysis was conducted on 163 pediatric allo-HSCT recipients. Serum magnesium levels were measured at defined intervals post-transplant, and outcomes were correlated with CD4+ T cell recovery, time to engraftment, incidence of graft-versus-host disease (GVHD), and survival within 12 months. Iron status, including siderosis severity, was evaluated using imaging and laboratory parameters obtained from clinical records. Results: Patients who died within 12 months post-transplant exhibited significantly lower magnesium levels. Hypomagnesemia was associated with delayed CD4+ T cell recovery, prolonged engraftment, and an increased risk of acute GVHD. A strong inverse correlation was observed between magnesium levels and the severity of siderosis. Iron overload appeared to exacerbate magnesium deficiency. Additionally, the coexistence of hypomagnesemia and siderosis significantly increased the risk of immune dysfunction and early mortality. No significant association was found with chronic GVHD. Conclusions: Hypomagnesemia is a significant, early predictor of poor outcomes in pediatric allo-HSCT, particularly in the context of iron overload, underscoring the need for early intervention, including iron chelation and MRI, to improve outcomes.
Open AccessImpact of Iron Overload and Hypomagnesemia Combination on Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Outcomes
Background/Objectives: Pediatric allogeneic hematopoietic stem cell transplantation (allo-HSCT) is complicated by iron overload and hypomagnesemia, both contributing to immune dysfunction and post-transplant morbidity. The combined impact of these metabolic disturbances on pediatric allo-HSCT outcomes remains unexplored. This study aims to determine whether hypomagnesemia can serve as a prognostic biomarker for delayed immune reconstitution and explores its interplay with iron overload in predicting post-transplant complications and survival outcomes. Methods: A retrospective analysis was conducted on 163 pediatric allo-HSCT recipients. Serum magnesium levels were measured at defined intervals post-transplant, and outcomes were correlated with CD4+ T cell recovery, time to engraftment, incidence of graft-versus-host disease (GVHD), and survival within 12 months. Iron status, including siderosis severity, was evaluated using imaging and laboratory parameters obtained from clinical records. Results: Patients who died within 12 months post-transplant exhibited significantly lower magnesium levels. Hypomagnesemia was associated with delayed CD4+ T cell recovery, prolonged engraftment, and an increased risk of acute GVHD. A strong inverse correlation was observed between magnesium levels and the severity of siderosis. Iron overload appeared to exacerbate magnesium deficiency. Additionally, the coexistence of hypomagnesemia and siderosis significantly increased the risk of immune dysfunction and early mortality. No significant association was found with chronic GVHD. Conclusions: Hypomagnesemia is a significant, early predictor of poor outcomes in pediatric allo-HSCT, particularly in the context of iron overload, underscoring the need for early intervention, including iron chelation and MRI, to improve outcomes.
- Open Access
- 16 July 2025
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 91 (11) , 3201-3212
Paediatric rare diseases: Can large language models assist off‐label prescribing?
Aims: To evaluate the effectiveness and reliability of large language models (LLMs) in retrieving and synthesizing biomedical information to support off‐label drug prescribing in paediatric rare diseases, and to compare their performance with human‐authored references in terms of scientific rationale, adverse events and drug interactions. Methods: The study reviewed 20 cases of off‐label prescriptions in rare paediatric diseases using 4 LLMs (i.e., GPT‐4o, Sophos‐2, Claude‐3, Scopus AI). The queries addressed focused on scientific rationale, adverse events and drug interactions. The performance measures encompassed sensitivity, precision, accuracy, F1‐score, response quality and reference quality. A Global Performance Score integrated all measures. Results: After evaluating 2758 references and 480 responses, a significant discrepancy was found among 4 LLMs concerning Global Performance Score ( P = .001). Posthoc analysis showed that Scopus AI vs . GPT‐4o comparison was significant, with GPT‐4o showing higher values. Median LLM reference quality often surpassed human performance, yet variability limits conclusions regarding superiority. Conclusions: LLMs are capable of retrieving and synthesizing biomedical information, but performance varies depending on query type and search mode. These tools speed up retrieving relevant information to assess off‐label prescribing appropriateness. Despite the promise of artificial intelligence, human oversight remains critical to ensure data accuracy and reliability.
- 16 July 2025
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 91 (11) , 3201-3212
Open AccessPaediatric rare diseases: Can large language models assist off‐label prescribing?
Aims: To evaluate the effectiveness and reliability of large language models (LLMs) in retrieving and synthesizing biomedical information to support off‐label drug prescribing in paediatric rare diseases, and to compare their performance with human‐authored references in terms of scientific rationale, adverse events and drug interactions. Methods: The study reviewed 20 cases of off‐label prescriptions in rare paediatric diseases using 4 LLMs (i.e., GPT‐4o, Sophos‐2, Claude‐3, Scopus AI). The queries addressed focused on scientific rationale, adverse events and drug interactions. The performance measures encompassed sensitivity, precision, accuracy, F1‐score, response quality and reference quality. A Global Performance Score integrated all measures. Results: After evaluating 2758 references and 480 responses, a significant discrepancy was found among 4 LLMs concerning Global Performance Score ( P = .001). Posthoc analysis showed that Scopus AI vs . GPT‐4o comparison was significant, with GPT‐4o showing higher values. Median LLM reference quality often surpassed human performance, yet variability limits conclusions regarding superiority. Conclusions: LLMs are capable of retrieving and synthesizing biomedical information, but performance varies depending on query type and search mode. These tools speed up retrieving relevant information to assess off‐label prescribing appropriateness. Despite the promise of artificial intelligence, human oversight remains critical to ensure data accuracy and reliability.
- 14 March 2025
- Published by Wiley in X-Ray Spectrometry
- Vol. 54 (5) , 488-495
Bromine Distribution in Healthy and Diseased Ovarian Tissues Investigated by X‐Ray Fluorescence Microscopy: An Exploratory Study
Bromine (Br) is found in nature primarily as part of inorganic salts, with a significant presence in seawater, and is also found in soil, contributing to its natural occurrence in human and animal diets. As an element in the human body, bromine is essential for health, particularly as a cofactor for the enzyme peroxidase (PXDN). This role is critical for the formation of sulfilimine bonds within collagen IV, which are necessary for basement membrane assembly and proper tissue development. During collagen cross‐linking, bromine is released into the extracellular matrix, underscoring its important role in maintaining tissue structure. In our exploratory study, micro‐ and nano‐X‐ray fluorescence (XRF) imaging at two different synchrotron beamlines was used to analyse Br distribution in bovine ovarian sections, as well as in human healthy endometrium and ovarian endometriotic lesions. Bromine was found to be widely distributed in both normal ovarian and endometriotic tissues, with maximal concentrations in specific areas corresponding to follicles and vessel walls.
- 14 March 2025
- Published by Wiley in X-Ray Spectrometry
- Vol. 54 (5) , 488-495
Bromine Distribution in Healthy and Diseased Ovarian Tissues Investigated by X‐Ray Fluorescence Microscopy: An Exploratory Study
Bromine (Br) is found in nature primarily as part of inorganic salts, with a significant presence in seawater, and is also found in soil, contributing to its natural occurrence in human and animal diets. As an element in the human body, bromine is essential for health, particularly as a cofactor for the enzyme peroxidase (PXDN). This role is critical for the formation of sulfilimine bonds within collagen IV, which are necessary for basement membrane assembly and proper tissue development. During collagen cross‐linking, bromine is released into the extracellular matrix, underscoring its important role in maintaining tissue structure. In our exploratory study, micro‐ and nano‐X‐ray fluorescence (XRF) imaging at two different synchrotron beamlines was used to analyse Br distribution in bovine ovarian sections, as well as in human healthy endometrium and ovarian endometriotic lesions. Bromine was found to be widely distributed in both normal ovarian and endometriotic tissues, with maximal concentrations in specific areas corresponding to follicles and vessel walls.